Sampled Expand Global Footprint with New Lab in UK
New Lab Opening Brings Expanded Capabilities to European Clients
3000sqft Sampled SMART Lab expansion based in UK New capabilities for European clients focused on biosample research and analysis Capabilities include genomics, epigenomics, PBMC isolation, bioprocessing, DNA/RNA extraction and sample storage… Next-generation Sequencing Market Worth $14.8 Billion By 2030
Next-generation Sequencing Market Worth $14.8 Billion By 2030
The global next-generation sequencing market size is expected to reach USD 14.8 billion by 2030, registering a CAGR of 12.4% over the forecast period,...
GV20 Therapeutics Builds Experienced Leadership Team
GV20 Therapeutics Builds Experienced Leadership Team
– Esteemed cancer researcher and co-founder of GV20 Shirley Liu appointed as Chief Executive Officer – Drug development leaders Steven Landau and Ying...
Sequential awarded prestigious Innovate UK SMART Grant
Sequential awarded prestigious Innovate UK SMART Grant
Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing...
Illumina Invests in £30M to Advance Breakthroughs in Human Health
Illumina Invests in £30M to Advance Breakthroughs in Human Health
Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates Illumina, Inc. (NASDAQ: ILMN), a...